AdCre injection into the connecting lobe of the KRAS/p53 Oncopig generated pancreatic tumor with a frequency of 71%; OCM tumors were predominantly epithelial on histology, but less differentiated with respect to gene expression. This evidence concerns the gene KRAS and pancreatic neoplasm.